Eckert & Ziegler with Unchanged Dividend Proposal

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Dividend/Annual Results
Eckert & Ziegler with Unchanged Dividend Proposal
23.03.2023 / 18:33 CET/CEST
The issuer is solely responsible for the content of this announcement.

Berlin, 23 March 2023 - Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) closed FY 2022 with sales of 222.3 million EUR. Net income for the year rose by around 20% compared to the previous year's figure adjusted for special effects and reached 29.3 million EUR, which corresponds to earnings per share of 1.41 EUR. Based on these figures, Executive Board and Supervisory Board decided today to propose to the Annual General Meeting the payment of a dividend of EUR 0.50 per dividend-bearing share, as in the previous year.

The detailed annual financial statements for 2022 and the forecast for FY 2023 will be published on 30 March 2023. Eckert & Ziegler is again listed in the TecDAX since 20 March 2023.

About Eckert & Ziegler.
Eckert & Ziegler Strahlen- und Medizintechnik AG with nearly 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Contributing to saving lives.

For enquiries please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com 

23.03.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com